Media & Resources

Press Releases

IAVI Statement on the US Administration’s Proposed Full Fiscal Year 2018 Budget

May 25, 2017

The International AIDS Vaccine Initiative (IAVI) expresses deep concern over drastic cuts to HIV/AIDS biomedical research and development proposed in the U.S. President’s FY 18 budget. This budget is built on the unfortunate fallacy that the AIDS epidemic can be sustainably controlled using current tools. The proposed 18 percent cut to the President’s Emergency Plan for AIDS Research (PEPFAR) limits capacity…

Scientific Publications

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime Boost Vaccine Regimens

Scientific Publications

Stabilization of a soluble native like trimeric form of an efficiently cleaved Indian HIV 1 clade C envelope glycoprotein

Press Releases

Canadian Researcher Wins Grant to Explore Promising HIV Vaccine Candidate

May 18, 2017

Canadian Institutes of Health Research funds Gary Kobinger to develop HIV vaccine in partnership with IAVI.

Scientific Publications

Glycine Substitution at Helix to Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein

Scientific Publications

Particulate Array of Well Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach

Scientific Publications

Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan dependent HIV 1 broadly neutralizing antibodies

Scientific Publications

The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans

1…112 113114115 116…233 of 233

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI Statement on the US Administration’s Proposed Full Fiscal Year 2018 Budget

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime Boost Vaccine Regimens

Stabilization of a soluble native like trimeric form of an efficiently cleaved Indian HIV 1 clade C envelope glycoprotein

Canadian Researcher Wins Grant to Explore Promising HIV Vaccine Candidate

Glycine Substitution at Helix to Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein

Particulate Array of Well Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach

Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan dependent HIV 1 broadly neutralizing antibodies

The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans

Media & Resources

Filter by

Type

Health area

Location

Topic

Year

Journal

Publication

Fact sheet & publication type

IAVI Statement on the US Administration’s Proposed Full Fiscal Year 2018 Budget

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime Boost Vaccine Regimens

Stabilization of a soluble native like trimeric form of an efficiently cleaved Indian HIV 1 clade C envelope glycoprotein

Canadian Researcher Wins Grant to Explore Promising HIV Vaccine Candidate

Glycine Substitution at Helix to Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein

Particulate Array of Well Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach

Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan dependent HIV 1 broadly neutralizing antibodies

The Tetrameric Plant Lectin BanLec Neutralizes HIV through Bidentate Binding to Specific Viral Glycans

Subscription Type